When combined with a synthetic STING agonist, ADUS-100, BTZ responses were potentiated in a mouse MM model through a fortified infiltration of the tumors by T lymphocytes and an increased phosphorylation of TBK1 in vitro. This evidence concerns the gene STING1 and Miyoshi myopathy.